TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
QURE

Uniqure NV

Healthcare · Biotechnology

39.10$ +2.3% vs. previous close Closing price · As of: Sep 28, 2026

Investor relations

Report Dates

Investor relations overview for Uniqure NV (QURE): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/09/2026.

Next report 11/09/2026
Last report 07/29/2026
Earnings surprise by quarter (%)
Q3 23 · -143.1 % 23 Q4 23 · -4.8 % 23 Q1 24 · -8.6 % 24 Q2 24 · 6.9 % 24 Q3 24 · 9.7 % 24 Q4 24 · -178.8 % 24 Q1 25 · 21.5 % 25 Q2 25 · 21.1 % 25 Q3 25 · -58.7 % 25 Q4 25 · 48.3 % 25 Q1 26 · 2.7 % 26 Q2 26 · -50.6 % 26

EPS estimate beaten

Full history 26 of 48 quarters (54%)
Last 16 quarters 8 of 16 quarters (50%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 09/02/2026 uniQure N.V. (QURE): Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?